Adoptive TIL Transfer in the Adjuvant Setting for Melanoma: Long-Term Patient Survival

Two first analyses of our clinical trial on TIL as adjuvant therapy for melanoma were published in 2002 and 2007. We present here an update of the clinical results after a 17-year median followup. In this trial, disease-free patients were randomly assigned to receive either TIL/IL-2 or IL-2. The rel...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Khammari, Amir, Knol, Anne-Chantal, Nguyen, Jean-Michel, Bossard, Céline, Denis, Marc-Guillaume, Pandolfino, Marie-Christine, Quéreux, Gaëlle, Bercegeay, Sylvain, Dréno, Brigitte
Formato: Artigo
Idioma:Inglês
Publicado em: Hindawi Publishing Corporation 2014
Assuntos:
Clinical Study
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3987883/
https://ncbi.nlm.nih.gov/pubmed/24741578
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2014/186212
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados